Popular Trials
Behavioral Intervention
Mindfulness Meditation-Enhanced Cognitive Behavioral Therapy for Binge Eating Disorder
This trial will test a new therapy program for binge eating disorder that combines mindfulness and cognitive behavioral therapy over 18 weeks. The researchers are first testing the program's feasibility and acceptability in a single-arm
Behavioural Intervention
Personalized Treatment for Eating Disorders
This trial aims to develop a personalized treatment for eating disorders (EDs) by considering individual factors and social context. Current treatments for EDs have limited success, and there is a need for more effective
Behavioral Intervention
Self-help Therapy for Teen Binge Eating Disorder
This trial is testing a new form of therapy for binge eating. Participants will be assessed at the beginning and then undergo five months of treatment, including self-monitoring and weekly therapy sessions. After treatment,
Behavioural Intervention
Personalized Treatment vs Cognitive Behavioral Therapy for Eating Disorders
This trial is testing a new, personalized treatment for eating disorders (ED), which may be more effective than the current gold-standard treatment. The study goals are to develop and test the new treatment, and to see if it works by targeting specific areas identified in each individual's network.
Behavioural Intervention
Behavioral Therapy for Eating Disorders
This trial is designed to study the independent and combined effects of four components of mindfulness-based behavioral therapy on eating pathology. The four components are Mindful Awareness, Distress Tolerance, Emotion Modulation, and Values-Based Decision Making. The trial will compare the efficacy of each component when used alone and in combination with standard behavioral treatment for bulimia nervosa and binge eating disorder. The primary aim of the study is to evaluate the independent efficacy of each treatment component on eating pathology. Secondary aims are to test the hypotheses that the efficacy of each component is moderated by related baseline deficits in self-regulation, and to quantify the component interaction
Popular Filters
Trials for BED Patients
Behavioral Intervention
Digital Intervention for Binge Eating Disorder in Black Women
This trial found Black women are more likely to binge eat & struggle to get effective treatment. To reduce weight-related concerns, culturally-relevant treatments for binge eating must be available to Black women.
Behavioural Intervention
Digital Health Tech + Behavioral Therapy for Eating Disorders
This trial is testing how well two types of self-monitoring (tracking what you eat and how you feel) and two types of micro-interventions (daily reminders and weekly check-ins) work when combined with standard cognitive behavioral therapy for bulimia nervosa and binge eating disorder.
Behavioral Intervention
Cognitive Behavioral Therapy for Eating Disorders
This trial will test a new, state of the art treatment for eating disorders that can be done virtually, making it more accessible to those who need it. The goal is to improve clinical outcomes and make a real-world impact among diverse and underrepresented eating disorder populations.
Circadian Rhythm Interventions for Binge Eating Disorder
This trial tests if exposing patients with Binge Eating Disorder to morning light and giving them a Melatonin pill can help reset their body clock and reduce binge eating. Melatonin is a hormone involved in appetite regulation and food intake, and its supplementation has been studied for its potential to restore balance in cases of circadian disruption. The study focuses on obese adults aged 18-50.
Compassionate Letter-Writing for Eating Disorders
This trial tests if writing self-compassionate letters can help patients with eating disorders feel less shame and be kinder to themselves. Participants will write these letters for a short period before starting their regular treatment. This approach aims to build self-compassion and reduce shame, which are believed to contribute to the maintenance and alleviation of eating disorders.
Trials for Bulimia Nervosa Patients
Behavioural Intervention
Digital Health Tech + Behavioral Therapy for Eating Disorders
This trial is testing how well two types of self-monitoring (tracking what you eat and how you feel) and two types of micro-interventions (daily reminders and weekly check-ins) work when combined with standard cognitive behavioral therapy for bulimia nervosa and binge eating disorder.
Behavioral Intervention
Cognitive Behavioral Therapy for Eating Disorders
This trial will test a new, state of the art treatment for eating disorders that can be done virtually, making it more accessible to those who need it. The goal is to improve clinical outcomes and make a real-world impact among diverse and underrepresented eating disorder populations.
Compassionate Letter-Writing for Eating Disorders
This trial tests if writing self-compassionate letters can help patients with eating disorders feel less shame and be kinder to themselves. Participants will write these letters for a short period before starting their regular treatment. This approach aims to build self-compassion and reduce shame, which are believed to contribute to the maintenance and alleviation of eating disorders.
Phase 3 Trials
Behavioural Intervention
Naltrexone + Bupropion for Binge Eating Disorder and Obesity
This trial will compare the effectiveness of a combination of naltrexone and bupropion medication to placebo in patients with obesity who have not responded to other treatments for binge-eating disorder.
Combination Drug
Medication + Behavioral Therapy for Post-Bariatric Surgery Weight Control
This trial will test different treatments for people who have trouble controlling their eating and weight after weight-loss surgery. The treatments include behavior therapy to change eating habits and a combination of two medications to reduce cravings. The goal is to find out which approach works best for these patients.
Behavioural Intervention
Lisdexamfetamine for Post-Bariatric Surgery Weight Control
This trial is testing whether the drug lisdexamfetamine can help people who have had weight-loss surgery but still struggle with controlling their eating and weight. The study focuses on those who did not improve with initial treatments, to see if this medication works better.
Trials With No Placebo
Behavioral Intervention
Digital Intervention for Binge Eating Disorder in Black Women
This trial found Black women are more likely to binge eat & struggle to get effective treatment. To reduce weight-related concerns, culturally-relevant treatments for binge eating must be available to Black women.
Behavioural Intervention
Digital Health Tech + Behavioral Therapy for Eating Disorders
This trial is testing how well two types of self-monitoring (tracking what you eat and how you feel) and two types of micro-interventions (daily reminders and weekly check-ins) work when combined with standard cognitive behavioral therapy for bulimia nervosa and binge eating disorder.
Behavioral Intervention
Cognitive Behavioral Therapy for Eating Disorders
This trial will test a new, state of the art treatment for eating disorders that can be done virtually, making it more accessible to those who need it. The goal is to improve clinical outcomes and make a real-world impact among diverse and underrepresented eating disorder populations.
Compassionate Letter-Writing for Eating Disorders
This trial tests if writing self-compassionate letters can help patients with eating disorders feel less shame and be kinder to themselves. Participants will write these letters for a short period before starting their regular treatment. This approach aims to build self-compassion and reduce shame, which are believed to contribute to the maintenance and alleviation of eating disorders.
Frequently Asked Questions
Introduction to binge eating disorder
What are the top hospitals conducting binge eating disorder research?
When it comes to the battle against binge eating disorder (BED), several prestigious hospitals are leading the way in clinical trials. In Philadelphia, Drexel University's Stratton Hall is at the forefront of cutting-edge research with three active BED trials and a total of five conducted studies on this condition. Their commitment to finding solutions for BED dates back to their first recorded trial in 2018. Meanwhile, Yale Department of Psychiatry in New Haven stands shoulder-to-shoulder with Drexel, conducting three ongoing BED trials and having completed four previous investigations since pioneering their initial study in 2007.
Notably, Lindner Center of HOPE located in Mason has made significant contributions to understanding and treating BED as well. With two active clinical trials underway and an impressive history of eight prior studies spanning from its inaugural investigation dating back to 2006, this center continues to push boundaries for better outcomes for individuals affected by this disorder.
Philadelphia's main campus at Drexel University also plays a crucial role in addressing the challenges posed by binge eating disorder. Although currently focusing on one active trial, they have demonstrated their dedication through six past investigations initiated as early as 2015.
Lastly but certainly not least important is The Yale Medical School Department of Psychiatry situated within New Haven; while still new entrants into researching about Binge Eating Disorder(BED) they show tremendous promise with one ongoing trial commencing just recently alongwith giving out effort towards enabling positive change for numerous affected patients already seen working towards ensuring sustainable support mechanisms starting from2022
These esteemed institutions symbolize hope for those battling binge eating disorder - offering new possibilities through innovative treatments and interventions rooted firmly within evidence-based research. As these hospitals continue their efforts collectively or individually across locations nationwide,this provides assurance that no stone will be left unturned until we discover effective methods not only managing but overcoming Binge Eating Disorders
Which are the best cities for binge eating disorder clinical trials?
When it comes to clinical trials for binge eating disorder, several cities are at the forefront of research. Philadelphia, Pennsylvania and New Haven, Connecticut each have 4 active trials focused on interventions such as Cognitive Behavioral Therapy (CBT), Mindful Awareness, and medication options like LDX and Naltrexone/Bupropion. Mason, Ohio follows closely with 3 ongoing trials exploring treatments like light therapy and medications such as Solriamfetol and Lisdexamfetamine. Additionally, Hamilton in Ontario offers one trial centered around a self-compassionate letter-writing intervention while Belmont in Massachusetts focuses on a Talking Activity intervention. These cities provide individuals struggling with binge eating disorder access to groundbreaking clinical trials that aim to improve understanding and treatment approaches for this challenging condition.
Which are the top treatments for binge eating disorder being explored in clinical trials?
In the realm of clinical trials for binge eating disorder treatments, two notable contenders have emerged. One is Behavioral Therapy for Eating Disorders, currently involved in one active trial and a total of two all-time trials dedicated to addressing binge eating disorder. This treatment approach made its debut in 2020 and shows promise in helping individuals overcome this challenging condition. Another option being explored is Cognitive behavioral therapy guided self-help (CBTgsh), which entered the scene more recently in 2022. It too has one ongoing trial specifically targeting binge eating disorder, showcasing its potential as an effective intervention method. As researchers delve deeper into these therapies, hope grows stronger for improved outcomes among those affected by binge eating disorder.
What are the most recent clinical trials for binge eating disorder?
Recent clinical trials have shed light on potential breakthroughs for individuals struggling with binge eating disorder. Psychotherapy has emerged as a promising avenue, showing positive results in Phase 2 studies conducted since March 2022. Additionally, solriamfetol, which completed its Phase 4 trial by June 2021, holds promise as a treatment option. Another innovative approach involves combining morning light exposure and melatonin supplementation to address this disorder—an intervention that has progressed through Phases 1 and 2 since January 2021. Furthermore, the Space From Body and Eating Concerns-Teen program aims to provide support specifically tailored for adolescents dealing with binge eating disorder following their successful completion of Phase 1 testing in December 2020. Lastly, naltrexone and bupropion showcased potential benefits during their combined Phase 2/Phase3 trial period ending in August 2019. These recent clinical trials offer hope for individuals affected by this challenging condition while paving the way for improved treatments moving forward.
What binge eating disorder clinical trials were recently completed?
Recently, several clinical trials investigating treatments for binge eating disorder have reached completion, providing valuable insights into this complex condition. In February 2021, Idorsia Pharmaceuticals Ltd. successfully concluded a trial examining the potential of ACT-539313 as a therapeutic option. Additionally, in April 2018, Yale University completed a trial evaluating the effectiveness of Bupropion Hydrochloride and Naltrexone Hydrochloride Drug Combination. Prior to that, in September 2017 and August 2017 respectively, Yale University wrapped up two separate trials involving NB medication (Naltrexone Bupropion combination). Lastly, in February 2017, another trial focusing on NB medication (Naltrexone Bupropion combination) was also completed at Yale University. These important studies contribute significantly to our understanding and treatment options for individuals with binge eating disorder.